547 filings
Page 8 of 28
8-K
m43juj367buk1f3mof
20 Dec 18
Galectin Therapeutics Announces Extension of $10 Million Line Credit
8:25am
8-K
pavlkothcxxue11vm
13 Nov 18
Galectin Therapeutics Reports 2018 Third Quarter
7:55am
424B3
cavrp qerxbg1cy
25 Sep 18
Prospectus supplement
12:28pm
8-K
1wbwp7 ozzlre
20 Sep 18
Galectin Therapeutics, Inc. Announces Positive Preliminary Results
7:51am
EFFECT
uwr8g5zhp3isu
10 Sep 18
Notice of effectiveness
12:00am
CORRESP
aq266v
6 Sep 18
Correspondence with SEC
12:00am
8-K
glnorvu3bc 1ouhej4o4
14 Aug 18
Galectin Therapeutics Reports 2018 Second Quarter Financial Results and Provides Business Update
7:55am
UPLOAD
w5m0li47nkoftvwnc2kt
10 Aug 18
Letter from SEC
12:00am
S-8
6ah rt50eu
26 Jun 18
Registration of securities for employees
4:17pm
8-K
vie3f8x
15 Jun 18
Departure of Directors or Certain Officers
12:00am
8-K
71ftgyto0w
12 Jun 18
Galectin Therapeutics Inc. Announces New CEO
8:30am
8-K
c03cguz7g
29 May 18
Departure of Directors or Certain Officers
9:00am
8-K
r7yny5yf7y2cyr3gbsnl
14 May 18
Galectin Therapeutics Proceeds to Phase 3 Development ofGR-MD-02 for NASH Cirrhosis Following FDA Meeting
9:01am
8-K
7z1twc2182ci ngg
11 May 18
Galectin Therapeutics Reports 2018 First Quarter Financial
4:11pm